John Risley's NPC invests $16.4 mln in growth of MicroSintesis
MicroSintesis, a Charlottetown, Prince Edward Island-based developer of novel anti-infectives, has raised $16.4 million in financing. The investor was Northern Private Capital (NPC), an investment arm of CFFI Ventures, the holding company of Canadian billionaire John Risley. The deal gave NPC a minority stake. MicroSintesis has created a microbiome platform for developing products that support animal and human health and wellness. Last year, it launched its first commercial brands, Ygia and Nuvio, for Canada's pet and livestock markets. The company will use the funds raised for scaling-up production, increasing research capabilities, and global growth. Founded in 2011, MicroSintesis is led by President and CEO Hannah McIver.
26 June 2019•4 mins read
